ArticleJournal of the American Board of Family Medicine : JABFM
Diffusion of breast cancer risk assessment in primary care.
Article in Journal of the American Board of Family Medicine : JABFM. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.Journal of general internal medicine · 2017Pooled it
- Trial
- Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.BMC health services research · 2022Trial
- Accuracy of ovarian and colon cancer risk assessments by U.S. physicians.Journal of general internal medicine · 2014Trial
- Impact of Affordable Care Act Provisions on the Racial Makeup of Patients Enrolled at a Deep South, High-Risk Breast Cancer Clinic.Journal of racial and ethnic health disparities · 2025Article
- Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: A mixed methods study.Genetics in medicine : official journal of the American College of Medical Genetics · 2025Article
- Review
- Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.AJR. American journal of roentgenology · 2021Article
- Perception of Breast Cancer Risk in Over 11,000 Patients During Routine Mammography Exam.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020Article
- Communicating cancer risk in the primary care consultation when using a cancer risk assessment tool: Qualitative study with service users and practitioners.Health expectations : an international journal of public participation in health care and health policy · 2020Article
- Calling on Primary Care to Prevent BRCA-Related Cancers.Journal of general internal medicine · 2020Article
- A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.Cancer · 2018Article
- How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?NPJ breast cancer · 2017Article
- The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes.Familial cancer · 2016Article
- Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2016Article
- Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.Journal of oncology practice · 2015Article
- Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2015Article
- Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.Current breast cancer reports · 2012Article
- Barriers in identification and referral to genetic counseling for familial cancer risk: the perspective of genetic service providers.Journal of genetic counseling · 2011Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPhysicians who provide primary care to women have the opportunity to identify patients at high risk for breast cancer who are candidates for risk reduction strategies. Our objective was to determine the prevalence and determinants of the adoption of breast cancer risk assessment by primary care physicians.
methodsA cross-sectional survey of a nationally representative random sample of 351 internists, family practitioners, and obstetricians-gynecologists. We used a questionnaire that assessed knowledge, attitudes, discussion of breast cancer risk, use of software to calculate breast cancer risk, and ordering of BRCA1/2 testing.
resultsEighty-eight percent of physicians reported discussing breast cancer risk at least once during the previous 12 months; 48% had ordered or referred a patient for BRCA1/2 testing; and 18% had used a software program to calculate breast cancer risk. Physicians who had used BRCA1/2 testing or discussed breast cancer risk factors were more likely to be obstetrician-gynecologists and not in a solo practice; the use of risk software was also more common among obstetrician-gynecologists but was also associated with having a family member with breast cancer and a greater knowledge about breast cancer risk. Having patients ask for risk information was associated with the discussion of risk factors but not with the other risk assessment strategies.
conclusionsDiffusion of breast cancer risk assessment is occurring in primary care practices, with a greater adoption of BRCA1/2 testing than of the use of risk assessment software. Adoption of these strategies seems to be related to the salience of breast cancer personally (for the physician) and within the practice, as well as the size of the practice, rather than attitudes about the risk assessment methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.